- USD/INR refreshes intraday low, bears retake controls after two-day uptrend.
- US dollar steps back amid hopes of Fed’s Powell defending easy money, S&P retains India’s BBB- rating.
- US Treasury yields weigh on DXY, covid concerns remain elevated.
USD/INR takes offers around 74.52, down 0.16% intraday amid the initial Indian trading session on Wednesday. The Indian rupee (INR) pair refreshed the weekly high on Tuesday before recently snapping the two-day run-up on mixed clues.
India’s daily covid positivity rate remains less than 3.0% for consecutive 23 days with the latest addition of 38,792 infections. This suggests the Asian nation’s ability to keep the pandemic chained following the two waves, which in turn helps the INR.
Also on the positive side could be the global rating agency S&P’s intact rating outlook for India while citing the country's strong external settings. Additionally, the US dollar pullback from the monthly top, amid the first daily negative performance of US Treasury yields, also weighs on the USD/INR prices.
It should, however, be noted that the strong US Consumer Price Index (CPI) data, published the previous day, backs Fed tapering concerns while suggesting the safe-haven buying of the US dollar. On the same line, escalating coronavirus (COVID-19) woes in the Asia-Pacific and West add to the greenback’s risk-safe demand.
Amid these plays, US stocks futures and Treasury yields remain pressured with eyes on the covid updates for immediate directions.
However, Fed Chairman Jerome Powell’s Testimony on the Semi-Annual Monetary Policy Report before the House Financial Services Committee will be the key. Although Fed’s Powell is likely to reiterate the “transitory” outlook for price pressures, amid mixed details of CPI, any surprises won’t be taken lightly.
MACD flashes the first bearish sign since June 01 but a 13-day-old support line near 74.40 could test short-term USD/INR losses. Meanwhile, bulls remain directed towards the 75.00 threshold unless breaking 74.35 support confluence including 21-DMA and a three-week-old rising trend line.
Additional important levels
|Today last price||74.531|
|Today Daily Change||-0.1210|
|Today Daily Change %||-0.16%|
|Today daily open||74.652|
|Previous Daily High||74.685|
|Previous Daily Low||74.4034|
|Previous Weekly High||74.9115|
|Previous Weekly Low||74.2544|
|Previous Monthly High||74.5135|
|Previous Monthly Low||72.4854|
|Daily Fibonacci 38.2%||74.5774|
|Daily Fibonacci 61.8%||74.511|
|Daily Pivot Point S1||74.4753|
|Daily Pivot Point S2||74.2985|
|Daily Pivot Point S3||74.1937|
|Daily Pivot Point R1||74.7569|
|Daily Pivot Point R2||74.8617|
|Daily Pivot Point R3||75.0385|
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.